Medtronic plc (0Y6X.L)
USD 82.7
(0.68%)
USD 82.7
(0.68%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 23.67 Billion USD | 3.74% |
| 2022 | 23.87 Billion USD | 12.22% |
| 2021 | 21.27 Billion USD | -10.67% |
| 2020 | 23.81 Billion USD | 10.23% |
| 2019 | 21.6 Billion USD | 3.21% |
| 2018 | 20.93 Billion USD | -5.24% |
| 2017 | 22.08 Billion USD | -22.43% |
| 2016 | 28.47 Billion USD | 0.88% |
| 2015 | 28.22 Billion USD | -10.1% |
| 2014 | 31.39 Billion USD | 198.4% |
| 2013 | 10.52 Billion USD | 8.07% |
| 2012 | 9.73 Billion USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 26.5 Billion USD | 7.23% |
| 2023 Q4 | 24.76 Billion USD | 5.11% |
| 2023 FY | 24.76 Billion USD | 3.74% |
| 2023 Q1 | 23.64 Billion USD | -0.95% |
| 2023 Q3 | 23.55 Billion USD | -0.88% |
| 2023 Q2 | 23.76 Billion USD | 0.53% |
| 2022 Q3 | 23.6 Billion USD | 8.34% |
| 2022 Q1 | 21.07 Billion USD | -0.94% |
| 2022 FY | 23.87 Billion USD | 12.22% |
| 2022 Q4 | 23.87 Billion USD | 1.11% |
| 2022 Q2 | 21.78 Billion USD | 3.41% |
| 2021 Q1 | 22.96 Billion USD | -3.57% |
| 2021 Q3 | 21.67 Billion USD | -4.61% |
| 2021 Q4 | 21.27 Billion USD | -1.87% |
| 2021 Q2 | 22.72 Billion USD | -1.03% |
| 2021 FY | 21.27 Billion USD | -10.67% |
| 2020 Q1 | 22.19 Billion USD | 3.57% |
| 2020 FY | 23.81 Billion USD | 10.23% |
| 2020 Q2 | 23.58 Billion USD | 6.3% |
| 2020 Q3 | 25.24 Billion USD | 7.03% |
| 2020 Q4 | 23.81 Billion USD | -5.68% |
| 2019 FY | 21.6 Billion USD | 3.21% |
| 2019 Q3 | 22.71 Billion USD | 0.97% |
| 2019 Q2 | 22.49 Billion USD | 2.38% |
| 2019 Q1 | 21.97 Billion USD | 5.03% |
| 2019 Q4 | 21.42 Billion USD | -5.69% |
| 2018 Q3 | 21.33 Billion USD | 1.0% |
| 2018 Q2 | 21.12 Billion USD | 1.26% |
| 2018 Q1 | 20.86 Billion USD | -5.61% |
| 2018 FY | 20.93 Billion USD | -5.24% |
| 2018 Q4 | 20.92 Billion USD | -1.94% |
| 2017 Q1 | 29.33 Billion USD | 2.98% |
| 2017 Q3 | 22.47 Billion USD | -4.57% |
| 2017 Q4 | 22.1 Billion USD | -1.66% |
| 2017 FY | 22.08 Billion USD | -22.43% |
| 2017 Q2 | 23.55 Billion USD | -19.7% |
| 2016 Q3 | 29.41 Billion USD | -0.23% |
| 2016 FY | 28.47 Billion USD | 0.88% |
| 2016 Q2 | 29.48 Billion USD | 1.36% |
| 2016 Q4 | 28.48 Billion USD | -3.19% |
| 2016 Q1 | 29.09 Billion USD | 3.27% |
| 2015 FY | 28.22 Billion USD | -10.1% |
| 2015 Q4 | 28.17 Billion USD | -15.04% |
| 2015 Q3 | 33.15 Billion USD | -1.15% |
| 2015 Q2 | 33.54 Billion USD | 2.84% |
| 2015 Q1 | 32.62 Billion USD | 3.9% |
| 2014 FY | 31.39 Billion USD | 198.4% |
| 2014 Q3 | 11.66 Billion USD | -6.06% |
| 2014 Q2 | 12.42 Billion USD | 8.35% |
| 2014 Q1 | 11.46 Billion USD | 8.95% |
| 2014 Q4 | 31.39 Billion USD | 169.09% |
| 2013 Q1 | 10.36 Billion USD | 6.48% |
| 2013 Q3 | 10.92 Billion USD | -2.61% |
| 2013 FY | 10.52 Billion USD | 8.07% |
| 2013 Q4 | 10.52 Billion USD | -3.72% |
| 2013 Q2 | 11.22 Billion USD | 8.25% |
| 2012 Q3 | -1.29 Billion USD | 0.0% |
| 2012 FY | 9.73 Billion USD | 0.0% |
| 2012 Q4 | 9.73 Billion USD | 850.08% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 31447.552% |
| Accuray Incorporated | 103.58 Million USD | -22759.267% |
| Align Technology, Inc. | -840.47 Million USD | 2917.352% |
| Elevance Health Inc. | 18.59 Billion USD | -27.348% |
| AxoGen, Inc. | 32.26 Million USD | -73286.847% |
| Boston Scientific Corporation | 8.23 Billion USD | -187.646% |
| CVS Health Corporation | 71.18 Billion USD | 66.738% |
| Cardinal Health, Inc. | 476 Million USD | -4874.58% |
| Centene Corporation | 506 Million USD | -4579.644% |
| DaVita Inc. | 10.65 Billion USD | -122.301% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 42.139% |
| Hologic, Inc. | 374.4 Million USD | -6224.519% |
| Humana Inc. | 5.51 Billion USD | -329.045% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -4693.824% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | -337.092% |
| Masimo Corporation | 804 Million USD | -2845.149% |
| McKesson Corporation | 889 Million USD | -2563.555% |
| Patterson Companies, Inc. | 648.47 Million USD | -3551.473% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | -405.637% |
| ResMed Inc. | 635.57 Million USD | -3625.609% |
| Henry Schein, Inc. | 2.57 Billion USD | -821.362% |
| Teladoc Health, Inc. | 468.6 Million USD | -4953.115% |
| Universal Health Services, Inc. | 5.24 Billion USD | -351.27% |
| Veeva Systems Inc. | -647.71 Million USD | 3755.791% |
| Baxter International Inc. | 11.16 Billion USD | -112.063% |
| Becton, Dickinson and Company | 14.46 Billion USD | -63.721% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 990.088% |
| Danaher Corporation | 13.49 Billion USD | -75.504% |
| Stryker Corporation | 10.02 Billion USD | -136.223% |